PRF Technologies Ltd.

PRF Technologies Ltd. announced its plan to establish GridFeed™, its AI-driven renewable energy trading platform, as a standalone, wholly owned subsidiary. This strategic move is intended to allow GridFeed to pursue direct investment, partnerships, and commercial collaborations with renewable energy producers, traders, and investors. The platform leverages AI technology for energy trading and forecasting, and PRF has filed a patent for its microclimate forecasting technology. GridFeed will be presented at Energy Trading Week Europe.

PRF Technologies Ltd. issued a Letter to Shareholders, announcing it raised $10 million through an equity line facility, significantly strengthening its financial position. The company highlighted building momentum across its biotechnology and AI-driven energy platforms. Key advancements include LayerBio's preparations for the Phase 2 clinical trial of OcuRing™-K and DeepSolar's validation of its Predict™ platform with real-world data, expansion into Battery-to-Revenue Intelligence, and joining the NVIDIA Connect program.

PRF Technologies issued a Letter to Shareholders detailing its first-half 2026 progress and strategic priorities. The company significantly strengthened its financial position by raising $10 million through an equity line facility. Key advancements include LayerBio progressing towards a Phase 2 clinical trial for OcuRing™-K and positive preclinical results for PRF-110. Additionally, the DeepSolar platform validated its Predict™ platform, expanded its capabilities, and joined the NVIDIA Connect program.

PRF Technologies announced that its DeepSolar business unit will showcase its GridFeed™ platform at Energy Trading Week Europe 2026 in London. The event, scheduled for September 24-25, 2026, is expected to draw over 2,500 market participants. GridFeed™ is an AI-driven platform designed for renewable energy trading, market participation, and revenue optimization, building on the company's DeepSolar Predict™ AI engine. This participation marks a significant step in PRF's go-to-market strategy to advance GridFeed from analytics to market decision support.

PRF Technologies Ltd. announced the expansion of its AI-driven DeepSolar Predict™ platform with a new "Battery-to-Revenue Intelligence" capability. This new feature is designed to optimize battery energy storage assets by connecting storage availability, operational constraints, and market conditions into decision-support workflows for revenue optimization. The company believes this will help renewable energy operators make higher-value market decisions and maximize the value of their assets, especially as global battery storage capacity is projected to grow significantly by 2030. This launch follows successful validation and is expected to be a core component of PRF's upcoming GridFeed™ platform.

PRF Technologies Ltd. announced that its DeepSolar business unit has successfully completed an initial validation phase for its DeepSolar Predict™ AI platform. This platform is designed for renewable energy revenue optimization and was validated using real-world European market data, including utility-scale datasets and market conditions. The validation evaluated the platform's optimization recommendations across day-ahead and intraday scenarios, marking a crucial step towards its planned commercial launch.

PRF Technologies announced that its DeepSolar business unit has completed the initial validation phase for DeepSolar Predict™, an AI-driven revenue optimization platform. This validation, utilizing real-world historical data from European energy markets, marks a crucial step towards the solution's planned commercial launch. DeepSolar Predict aims to help renewable energy operators manage financial exposure and maximize revenue by transforming operational and market data into actionable recommendations.

PRF Technologies Ltd. announced expanded preclinical results for its lead product candidate, PRF-110, in a head-to-head comparison with ZYNRELEF. The study showed PRF-110 had comparable analgesic efficacy, slower absorption, and enhanced local tissue retention. These findings reinforce PRF-110's potential as a long-acting, single-administration post-operative analgesic, aiming to reduce opioid use.

PRF Technologies Ltd. announced expanded preclinical study results for its lead product candidate, PRF-110, comparing it to ZYNRELEF®. The study showed PRF-110 had comparable analgesic efficacy to the benchmark, along with a favorable pharmacokinetic profile characterized by slower absorption and enhanced local tissue retention. These findings reinforce confidence in PRF-110 as a differentiated, long-acting solution for post-operative pain management, aiming to reduce opioid use.

PRF Technologies Ltd. entered into a Standby Equity Purchase Agreement (SEPA) with YA, enabling the company to sell up to $15.0 million in ordinary shares to YA over a 36-month period. This agreement aims to raise capital for research and development, working capital, and general corporate purposes. However, the potential issuance of up to 7,500,000 shares, representing approximately 247% of current outstanding shares, carries a significant risk of substantial dilution and share price decline for existing shareholders. The company had previously terminated a $10.0 million SEPA with YA in May 2026.